Global Heart Q2
- 期刊收录:
- SCIE
- Scopus
- DOAJ
- 期刊ISSN:
2211-8160
- 期刊简拼:
GLOB HEART
- 年发文章数:
58
- E-ISSN:
2211-8179
- Gold OA文章占比
98.65%
- 研究文章占比:
77.59%
- 是否OA:
No
- Jcr分区:
Q2
- 中科院分区:
3区
- 出版商:
Elsevier Science & Technology
- 涉及研究方向:
Medicine-Cardiology and Cardiovascular Medicine
- 出版国家:
United Kingdom
- 出版语言:
English
- 出版周期:
- 出版年份:
- 2023-2024最新影响因子:3
- 自引率:3.30%
- 五年影响因子:3.5
- JCI期刊引文指标:0.78
- h-index:暂无h-index数据
- CiteScore:5.70
期刊简介
Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.
Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.
Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.
《Global Heart》期刊已被查看: 次
期刊简写:GLOB HEART
此期刊被最新的JCR期刊SCIE收录
期刊信息
- PubMed Central (PMC)链接
- http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-8160%5BISSN%5D
- 通讯地址
- 2N, 6 OSBORNE ST, LONDON, ENGLAND, E1 6TD
- 中国科学院《国际期刊预警名单(试行)》名单
-
2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
此期刊被最新的JCR期刊SCIE收录
- 审稿速度
- 收录数据库
- 是否oa
- 研究方向
- 5 Weeks
- SCIE,Scopus,DOAJ
- No
- Medicine-Cardiology and Cardiovascular Medicine
分区信息
- 大类学科
- 分区
- 小类学科
- Top期刊
- 综述期刊
- 医学
- 3区
- CARDIAC & CARDIOVASCULAR SYSTEMS
心脏和心血管系统 - 否
- 否
- 版本
- 按学科
- 分区
- 影响因子
- WOS期刊SCI分(2023-2024年最新版)
- CARDIAC & CARDIOVASCULAR SYSTEMS
- Q2
- 3
IF值(影响因子)趋势图
年发文量趋势图
自引率趋势图
中科院分区
常见问题
-
sci四区价格多少算合理?
一篇sci4区是sci里最便宜的了 价格一般在3-4左右,如果有人告诉你几k就能发或者五位数出头,个人建议谨慎一点,不能因为贪小便宜吃大亏如果四区就能满足学
《Global Heart》同类:医学期刊
-
MaternalFetal Medicine
JCR:0区--分类:医学
影响因子0
收录Scopus,DOAJ
-
Precision Clinical Medicine
JCR:1区--分类:医学
影响因子5.1
收录ESCI,Scopus,DOAJ
-
Arthroplasty
JCR:2区--分类:医学
影响因子2.3
收录ESCI,Scopus,DOAJ
-
JHEP Reports
JCR:1区--分类:医学
影响因子9.5
收录SCIE,Scopus,DOAJ
-
World Journal of Pediatric Surgery
JCR:4区--分类:医学
影响因子0.8
收录ESCI,Scopus,DOAJ
-
Human Reproduction Open
JCR:1区--分类:医学
影响因子8.3
收录SCIE,Scopus,DOAJ
-
Animal Models and Experimental Medicine
JCR:2区--分类:医学
影响因子3.8
收录ESCI,Scopus,DOAJ
-
Brazilian Journal of Anesthesiology
JCR:2区--分类:医学
影响因子1.7
收录SCIE,Scopus,DOAJ
- 上一篇: Big Data Research
- 下一篇:Botanical Studies